AEterna Zentaris Inc (NASDAQ:AEZS)

2.16
Delayed Data
As of 9:37am ET
 +0.0125 / +0.58%
Today’s Change
0.89
Today|||52-Week Range
3.29
-8.37%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$30.6M

Company Description

Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company that is engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. It operates through biopharmaceutical segment. AEterna Zentaris was founded on September 12, 1990 and is headquartered in Charleston, SC.

Contact Information

Æterna Zentaris, Inc.
315 Sigma Drive
Charleston South Carolina 29486
P:(843) 900-3223
Investor Relations:

Employees

Shareholders

Other institutional3.81%
Mutual fund holders0.08%
Individual stakeholders--

Top Executives

Michael V. WardPresident, CEO & Head-Media Relations
James ClavijoChief Financial Officer
Nicola AmmerChief Medical Officer & VP-Clinical Development
Michael TeifelVice President-Non Clinical Sciences
Eckhard G. GuentherVice President-Alliance Management